Table 4.
Study | n | Histology | Technical success, n (%) | Clinical success, n (%) | Procedural AEs, n (%) | Stent type | Mean follow-up (days) |
---|---|---|---|---|---|---|---|
Jang et al. [11] (2012) | 30 | Benign (30) | 29 (97) | 29 (100) | 2 (7) | NBT | N/D |
Choi et al. [12] (2014) | 63 | Benign/malignancy (22/41) | 62 (98.4) | 62 (98.4) | 3 (4.8) | MS | 275 |
Takagi et al. [13] (2016) | 16 | Benign/malignancy (4/14) | 16 (100) | 16 (100) | 0 (0) | MS and PS | 182 |
Tyberg et al. [14] (2018) | 42 | N/D | 40 (95) | 40 (95) | N/D | MS, PS | N/D |
Kamata et al. [15] (2017) | 12 | Benign/malignancy (1/11) | 12 (100) | 12 (100) | 0 (0) | MS | 304 |
Choi et al. [16] (2017) | 14 | Malignancy (14) | 12 (85.7) | 11(91.7) | 4 (28.5) | MS | 130 |
Irani et al. [17] (2015) | 15 | Benign/malignancy (9/6) | 14 (93) | 14 (100) | 1 (7) | LAMS | 160 |
Walter et al. [18] (2016) | 30 | N/D | 27 (90) | 26 (86.7) | 15 (50) | LAMS | 298 |
Kahaleh et al. [19] (2016) | 35 | Benign/malignancy (20/15) | 32 (91.4) | 31 (89) | (25) | LAMS, PS | 91.5 |
Irani et al. [20] (2017) | 45 | Benign/malignancy (29/16) | 44 (98) | 43 (96) | 8 (18) | LAMS, PS | 215 |
Dollhopf et al. [21] (2017) | 75 | Benign (53) | 74 (98.7) | 71 (95.9) | 8 (10.7) | LAMS | 201 |
Teoh et al. [22] (2017) | 59 | Benign (59) | 57 (96.6) | 53 (94.9) | 19 (32.2) | LAMS | 451 |
Manta et al. [23] (2018) | 226 | N/D | 215 (95.1) | 207 (91.6) | 24 (10.6) | LAMS | 180 |
Our study | 10 | Malignancy (10) | 9 (90) | 8 (89) | 4 (40) | MS, PS | 252 |
AE, adverse event; LAMS, lumen-apposing metal stent; MS, metal stent; NBT, nasobiliary drainage tube; N/D, not described; PS, plastic stent.